PUMA BIOTECHNOLOGY, INC. Deferred Tax Assets, Valuation Allowance
PUMA BIOTECHNOLOGY, INC. (PBYI) had Deferred Tax Assets, Valuation Allowance of $324.79 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Valuation Allowance $324.79M.
- 2025-09-30: Deferred Tax Assets, Valuation Allowance $7.00M.
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $343.48M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $368.75M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2025-12-31 | $324.79M 10-K · filed 2026-02-26 |
| 2025-09-30 | $7.00M 10-Q · filed 2025-11-06 |
| 2024-12-31 | $343.48M 10-K · filed 2026-02-26 |
| 2023-12-31 | $368.75M 10-K · filed 2026-02-26 |
| 2022-12-31 | $374.96M 10-K · filed 2025-02-27 |
| 2021-12-31 | $380.10M 10-K · filed 2024-02-29 |
| 2020-12-31 | $392.57M 10-K · filed 2023-03-02 |
| 2019-12-31 | $383.91M 10-K · filed 2022-03-03 |
| 2018-12-31 | $369.67M 10-K · filed 2020-02-28 |
| 2017-12-31 | $364.15M 10-K · filed 2019-03-01 |
| 2016-12-31 | $316.00M 10-K · filed 2018-03-09 |
| 2015-12-31 | $209.78M 10-K · filed 2017-03-01 |
| 2014-12-31 | $108.43M 10-K · filed 2016-02-29 |
| 2013-12-31 | $58.65M 10-K · filed 2015-03-02 |
| 2012-12-31 | $33.26M 10-K · filed 2014-03-03 |
| 2011-12-31 | $4.05M 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |